Search
Now showing items 1-10 of 15
Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina
(Baishideng Publishing Group Inc, 2018-01-27)
Abstract
Aim: To investigate any changing trends in the etiologies of hepatocellular carcinoma (HCC) in Argentina during the last years.
Methods: A longitudinal cohort study was conducted by 14 regional hospitals ...
Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates.
(Elsevier, 2017-08-01)
BACKGROUND:
The natural history of intrapulmonary vascular dilations (IPVD) and their impact on patient outcomes in the setting of portal hypertension has only been described in small series.
AIMS:
To assess the ...
Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update.
(Sociedad Argentina de Pediatría., 2017-06-01)
Lysosomal acid lipase deficiency (LAL-D) is still a little recognized genetic disease with significant morbidity and mortality in children and adults. This document provides guidance on when to suspect LAL-D and how to ...
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.
(Wiley, 2016-11-01)
BACKGROUND & AIMS:
The French alpha-fetoprotein (AFP) model has recently shown superior results compared to Milan criteria (MC) for prediction of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) ...
Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
(Fundación Clínica Médica Sur, A.C., 2018-03-01)
Background and aims. Heterogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and recurrence ...
Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina.
(Baishideng Publishing Group, 2018-01-27)
AIM:
To investigate any changing trends in the etiologies of hepatocellular carcinoma (HCC) in Argentina during the last years.
METHODS:
A longitudinal cohort study was conducted by 14 regional hospitals starting in ...
Incidence, risk factors, and outcomes related with neurological events after liver transplantation in adult and pediatric recipients.
(Wiley, 2018-02-07)
Controversy exists whether NE after LT are more frequently observed in children or adults. We aimed to compare the incidence and outcomes for NE after LT in pediatric and adult recipients. A single-center cohort study, ...
A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
(Elsevier B.V. ScienceDirect, 2019-04-15)
Abstract
Introduction and aim: A pro-oncogenic intestinal microbiome was observed in murine models; however, no specific microbiome in patients with hepatocellular carcinoma (HCC) has been reported. We aimed to compare ...
Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina
(Wolters Kluwer Health, Inc. All rights reserved, 2018-04-30)
Abstract
Background and aim
Adherence to the Barcelona Clinic Liver Cancer (BCLC) staging algorithm for the treatment of hepatocellular carcinoma is challenging in the daily practice. We aimed to analyze adherence to ...
Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
(Wolters Kluwer Health, Inc., 2016-04-28)
BACKGROUND AND AIM:
The Up-to-7 criteria on the basis of the explanted liver features categorize patients at higher risk of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). The aim of this study ...